Basic Information
ID: ALA4036183
Type: ADME
Description: Drug level treated with Sodium (S)-2-(4-(4-((((3Z,6Z)-6-benzylidene-3-((5-(tertbutyl)-1H-imidazol-4-yl)methylene)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl)oxy)methoxy)-4-oxobutyl)-1H-1,2,3-triazol-1-yl)pentanedioate assessed as porcine liver carboxylic-ester hydrolase-mediated metabolite formation after 48 hrs by HPLC method
Format: BAO_0000019
Organism: Sus scrofa
Target: Carboxylesterase(ALA3383)
Document: ALA4033713
Drug level treated with Sodium (S)-2-(4-(4-((((3Z,6Z)-6-benzylidene-3-((5-(tertbutyl)-1H-imidazol-4-yl)methylene)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl)oxy)methoxy)-4-oxobutyl)-1H-1,2,3-triazol-1-yl)pentanedioate assessed as porcine liver carboxylic-ester hydrolase-mediated metabolite formation after 48 hrs by HPLC method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4036183
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 30.03 | -0.18 | -0.18 |
| 336.40 | 0.74 | 0.74 |